Methodology for determining doses to in-field, out-of-field and partially in-field organs for late effects studies in photon radiotherapy

Physics in Medicine and Biology

Volumn 55, Issue 23, 2010, Pages 7009-7023

  Howell, Rebecca M ^a,b   Scarboro, Sarah B ^a,b   Taddei, Phillip J ^b   Krishnan, Sunil ^b   Kry, Stephen F ^a,b   Newhauser, Wayne D ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSORBED DOSE; HEPATOCELLULAR CARCINOMA; IN-FIELD; INTENSITY-MODULATED RADIOTHERAPY; LATE EFFECTS; LOW DOSE; MEAN DOSE; PATIENT DATA; PHOTON RADIOTHERAPY; RADIATION DOSIMETRY; SENSITIVITY TESTS; TREATMENT PLANNING SYSTEMS; WEIGHTING TECHNIQUES;

HOSPITAL DATA PROCESSING; RADIATION EFFECTS; RADIOTHERAPY;

DOSIMETRY;

ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; HUMAN; IMAGE QUALITY; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; ORGANS AT RISK; PHOTON; RADIATION DOSE; RADIATION EXPOSURE; RADIOMETRY; RADIOTHERAPY;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; ORGANS AT RISK; PHANTOMS, IMAGING; PHOTONS; RADIOMETRY; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 78650054416     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/55/23/S04     Document Type: Article

References (33)

1. Almond P R, Biggs P J, Coursey B M, Hanson W F, Huq M S, Nath R and Rogers D W O 1999 Aapm's TG-51 protocol for clinical reference dosimetry of high-energy photon and electron beams Med. Phys. 26 1847-70
2. Aspradakis M M, Morrison R H, Richmond N D and Steele A 2003 Experimental verification of convolution/superposition photon dose calculations for radiotherapy treatment planning Phys. Med. Biol. 48 2873-93
3. Bednarz B and Xu X G 2009 Monte Carlo modeling of a 6 and 18 MV Varian clinac medical accelerator for in-field and out-of-field dose calculations: development and validation Phys. Med. Biol. 54 N43-57
4. Bhatia S et al and Late Effects Study Group 2003 High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the late effects study group J. Clin. Oncol. 21 4386-94
5. Boice J D Jr, Day N E, Andersen A, Brinton L A, Brown R, Choi N W, Clarke E A, Coleman M P, Curtis R E and Flannery J T 1985 Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries J. Natl Cancer Inst. 74 955-75
6. Carr Z A, Kleinerman R A, Stovall M, Weinstock R M, Griem M L and Land C E 2002 Malignant neoplasms after radiation therapy for peptic ulcer Radiat. Res. 157 668-77
7. Chofor N, Harder D, Ruhmann A,Willborn K C,Wiezorek T and Poppe B 2010 Experimental study on photon-beam peripheral doses, their components and some possibilities for their reduction Phys. Med. Biol. 55 4011-27
8. Das I J, Cheng C W, Watts R J, Ahnesjo A, Gibbons J, Li X A, Lowenstein J, Mitra R K, Simon W E and Zhu T C 2008 Accelerator beam data commissioning equipment and procedures: report of the TG-106 of the therapy physics committee of the AAPM Med. Phys. 35 4186-215
9. Followill D S, Evans D R, Cherry C, Molineu A, Fisher G, Hanson W F and Lbbott G S 2007 Design, development, and implementation of the radiological physics center's pelvis and thorax anthropomorphic quality assurance phantoms Med. Phys. 34 2070-6
10. Fraass B A and van de Geijn J 1983 Peripheral dose from megavolt beams Med. Phys. 10 809-18
11. GoskeMJ et al 2009 The image gently campaign: working together to change practice Am. J. Roentgenol. 190 273-4
12. Howell R M, Scarboro S B, Kry S F and Yaldo Z 2010 Accuracy of out-of-field dose calculations by a commercial treatment planning system Phys. Med. Biol. 55 6999-7008
13. IbbottGS, MolineuAand FollowillDS 2006 Independent evaluations of IMRT through the use of an anthropomorphic phantom Technol. Cancer Res. Treat. 5 481-7
14. ICRU 1987 Use of computers in external beam radiotherapy procedures with high energy photons and electrons ICRU Report No 42 (Bethesda, MD: International Commission on Radiation Units and Measurements)
15. Kirby T H, Hanson W F, Gastorf R J, Chu C H and Shalek R J 1986 Mailable tld system for photon and electron therapy beams Int. J. Radiat. Oncol. Biol. Phys. 12 261-5
16. Kirby T H, Hanson W F and Johnston D A 1992 Uncertainty analysis of absorbed dose calculations from thermoluminescence dosimeters Med. Phys. 19 1427-33
17. Klein E E, Maserang B, Wood R and Mansur D 2006 Peripheral doses from pediatric IMRT Med. Phys. 33 2525-31
18. Kry S F, Titt U, Pèonisch F, Followill D, Vassiliev O N, White R A, Mohan R and Salehpour M 2006 A Monte Carlo model for calculating out-of-field dose from a Varian 6 MV beam Med. Phys. 33 4405-13
19. Lin H M and Teitell M A 2005 Second malignancy after treatment of pediatric Hodgkin disease J. Pediatr. Hematol. Oncol. 27 28-36
20. Meeks S L, Paulino A C, Pennington E C, Simon J H, Skwarchuk M W and Buatti J M 2002 In vivo determination of extra-target doses received from serial tomotherapy Radiother. Oncol. 63 217-22
21. Newhauser W D et al 2009 The risk of developing a second cancer after receiving craniospinal proton irradiation Phys. Med. Biol. 54 2277-91
22. Reft C S, Runkel-Muller R and Myrianthopoulos L 2006 In vivo and phantom measurements of the secondary photon and neutron doses for prostate patients undergoing 18 MV IMRT Med. Phys. 33 3734-42
23. Ron E 2003 Cancer risks from medical radiation Health Phys. 85 47-59
24. Rubino C, Adjadj E, Guerin S, Guibout C, Shamsaldin A, Dondon M G, Valteau-Couanet D, Hartmann O, Hawkins M and de Vathaire F 2003a Long-term risk of second malignant neoplasms after neuroblastoma in childhood: role of treatment Int. J. Cancer 107 791-6
25. Rubino C, de Vathaire F, Dottorini M E, Hall P, Schvartz C, Couette J E, Dondon M G, Abbas M T, Langlois C and Schlumberger M 2003b Second primary malignancies in thyroid cancer patients Br. J. Cancer 89 1638-44
26. Sievinen J, Ulmer W and Kaissl W 2005 AAA photon dose calculation model in eclipse Varian Medical Systems white paper (Palo Alto, CA: Varian Medical Systems)
27. Sigurdson A J et al 2005 Primary thyroid cancer after a first tumour in childhood (the childhood cancer survivor study): a nested case-control study Lancet 365 2014-23
28. Stovall M, Blackwell C R, Cundiff J, Novack D H, Palta J R, Wagner L K, Webster E W and Shalek R J 1995 Fetal dose from radiotherapy with photon beams: report of AAPM Radiation Therapy Committee Task Group no 36 Med. Phys. 22 63-82
29. Stovall M, Smith S A and Rosenstein M 1989 Tissue doses from radiotherapy of cancer of the uterine cervix Med. Phys. 16 726-33
30. Stovall M, Weathers R, Kasper C, Smith S A, Travis L, Ron E and Kleinerman R 2006 Dose reconstruction for therapeutic and diagnostic radiation exposures: use in epidemiological studies Radiat. Res. 166 141-57
31. Taddei P T, Howell RM, Scarboro S B, Krishnan S, Mirkovic D and NewhauserWD 2010 Risk of second malignant neoplasm following proton versus intensity modulated photon radiotherapy for hepatocellular carcinoma Phys. Med. Biol. 55 7055-65
32. Van Esch A, Tillikainen L, Pyykkonen J, Tenhunen M, Helminen H, Siljamaki S, Alakuijala J, Paiusco M, Lori M and Huyskens D P 2006 Testing of the analytical anisotropic algorithm for photon dose calculation Med. Phys. 33 4130-48
33. Xu X G, Bednarz B and Paganetti H 2008 A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction Phys. Med. Biol. 53 R193-241